BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang C, Zhang L, Ke L, Ding W, Jiang S, Li D, Narita Y, Hou I, Liang J, Li S, Xiao H, Gottwein E, Kaye KM, Teng M, Zhao B. Primary effusion lymphoma enhancer connectome links super-enhancers to dependency factors. Nat Commun 2020;11:6318. [PMID: 33298918 DOI: 10.1038/s41467-020-20136-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Xiao Q, Xiao Y, Li LY, Chen MK, Wu M. Multifaceted regulation of enhancers in cancer. Biochim Biophys Acta Gene Regul Mech 2022;1865:194839. [PMID: 35750313 DOI: 10.1016/j.bbagrm.2022.194839] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Kumar A, Lyu Y, Yanagihashi Y, Chantarasrivong C, Majerciak V, Salemi M, Wang KH, Inagaki T, Chuang F, Davis RR, Tepper CG, Nakano K, Izumiya C, Shimoda M, Nakajima KI, Merleev A, Zheng ZM, Campbell M, Izumiya Y. KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4. Cell Rep 2022;39:110788. [PMID: 35545047 DOI: 10.1016/j.celrep.2022.110788] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Chen ZX, Huang HQ, Wen JY, Qin LS, Song YD, Fang YY, Zeng DT, Huang WJ, Qin XG, Gan TQ, Luo J, Li JJ. Active Enhancer Assessment by H3K27ac ChIP-seq Reveals Claudin-1 as a Biomarker for Radiation Resistance in Colorectal Cancer. Dose Response 2021;19:15593258211058981. [PMID: 34987334 DOI: 10.1177/15593258211058981] [Reference Citation Analysis]
4 Shimoda M, Lyu Y, Wang KH, Kumar A, Miura H, Meckler JF, Davis RR, Chantarasrivong C, Izumiya C, Tepper CG, Nakajima KI, Tuscano J, Barisone G, Izumiya Y. KSHV transactivator-derived small peptide traps coactivators to attenuate MYC and inhibits leukemia and lymphoma cell growth. Commun Biol 2021;4:1330. [PMID: 34857874 DOI: 10.1038/s42003-021-02853-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Wang J, Wu Y, Uddin MN, Chen R, Hao JP. Identification of Potential Key Genes and Regulatory Markers in Essential Thrombocythemia Through Integrated Bioinformatics Analysis and Clinical Validation. Pharmgenomics Pers Med 2021;14:767-84. [PMID: 34267539 DOI: 10.2147/PGPM.S309166] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Kasprzyk ME, Sura W, Dzikiewicz-Krawczyk A. Enhancing B-Cell Malignancies-On Repurposing Enhancer Activity towards Cancer. Cancers (Basel) 2021;13:3270. [PMID: 34210001 DOI: 10.3390/cancers13133270] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
7 Gaglia MM. Kaposi's sarcoma-associated herpesvirus at 27. Tumour Virus Res 2021;12:200223. [PMID: 34153523 DOI: 10.1016/j.tvr.2021.200223] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
8 Soliman SHA, Orlacchio A, Verginelli F. Viral Manipulation of the Host Epigenome as a Driver of Virus-Induced Oncogenesis. Microorganisms 2021;9:1179. [PMID: 34070716 DOI: 10.3390/microorganisms9061179] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]